TABLE 2.
Echocardiographic findings of the study population and in survivors vs nonsurvivors
| Variable | Feasibility | Total | Survivors | Nonsurvivors | P‐value |
|---|---|---|---|---|---|
| LVEF, % | 49 (100%) | 53 ± 12 | 55 ± 12 | 49 ± 9 | .06 |
| LVESV index to body surface area, mL/m2 | 40 (82%) | 27 ± 15 | 26 ± 16 | 29 ± 15 | .55 |
| WMSI | 48 (98%) | 1.25 ± 0.45 | 1.17 ± 0.36 | 1.43 ± 0.56 | .09 |
| LV GLS, % | 32 (65%) | −15 ± 4 | −16 ± 4 | −12 ± 4 | .028 |
| Left atrial volume index to body surface area, mL/m2 | 42 (86%) | 32 ± 11 | 29 ± 9 | 39 ± 14 | .0041 |
| Right atrial‐ventricular gradient, mm Hg | 34 (69%) | 28 ± 9 | 25 ± 41 | 33 ± 10 | .010 |
| PASP, mm Hg | 19 (39%) | 33 ± 9 | 30 ± 7 | 39 ± 11 | .060 |
| TAPSE, mm | 45 (92%) | 20 ± 4 | 21 ± 5 | 18 ± 3 | .033 |
| TAPSE/PASP, mm/mm Hg | 18 (37%) | 0.62 ± 0.24 | 0.69 ± 0.23 | 0.44 ± 0.15 | .039 |
| FAC, % | 40 (82%) | 41 ± 8 | 42 ± 6 | 39 ± 11 | .36 |
| RV‐GLS % | 37 (76%) | −15 ± 5 | −17 ± 5 | −12 ± 4 | .008 |
| RV free wall strain, % | 38 (78%) | −18 ± 6 | −19 ± 5 | −14 ± 6 | .015 |
Continuous variables are reported as mean ± standard.
Abbreviations: FAC = fractional area‐change right ventricle; LVEF = Left ventricular ejection fraction; LVESV = left ventricular end‐systolic volume; LVGLS = left ventricular global longitudinal strain; PASP = pulmonary arterial systolic pressure; RV = right ventricular; RV‐GLS = right ventricular global longitudinal strain; TAPSE = tricuspidal annular plane systolic excursion; WMSI = wall motion score index.